
Emcure Pharmaceuticals Reports Strong Q4 FY25 Results with 19% Revenue Growth and 63% Increase in Profit After Tax
Emcure Pharmaceuticals has announced its consolidated financial results for the fourth quarter and full year
Emcure Pharmaceuticals has announced its consolidated financial results for the fourth quarter and full year
Emcutix Biopharmaceuticals Ltd in partnership with Canada-based Mantra Pharma Inc—both subsidiaries of Emcure Pharmaceuticals Ltd—has
Tillomed Laboratories Limited, the European arm of Emcure Pharmaceuticals Ltd., has entered into an Asset
Emcure Pharmaceuticals, a leading player in India’s pharmaceutical sector, has officially opened its advanced Formulation
Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) announced solid financial results for the quarter ending September 30,
Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) has announced its unaudited consolidated financial results for the quarter
Emcure Pharmaceuticals, backed by Bain Capital, will launch its Initial Public Offering (IPO) on July
© 2025 All Right Reserved Machine Maker